Radiologic and molecular remission of follicular T cell lymphoma treated with lenalidomide

[1] Huang Y(2009)Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas Am J Surg Pathol 33 682-690

[2] Moreau A(2016)The 2016 revision of the World Health Organization classification of lymphoid neoplasms Blood 127 2375-2390

[3] Dupuis J(2000)Peripheral T-cell lymphoma with distinct perifollicular growth pattern: a distinct subtype of T-cell lymphoma? Am J Surg Pathol 24 117-122

[4] Streubel B(2001)Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype Am J Surg Pathol 25 395-400

[5] Petit B(2006)Peripheral T-cell lymphoma with involvement of the expanded mantle zone Virchows Arch 449 78-87

[6] Le Gouill S(2012)Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics Am J Surg Pathol 36 1636-1646

[7] Martin-Garcia N(2004)Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients Blood 104 243-249

[8] Copie-Bergman C(2010)Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma Cancer 116 4541-4548

[9] Gaillard F(2013)A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trial Eur J Cancer 49 2869-2876

[10] Qubaja M(2015)Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T-cell lymphoma Cancer 121 716-723

[1] Huang Y(2009)Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas Am J Surg Pathol 33 682-690

[2] Moreau A(2016)The 2016 revision of the World Health Organization classification of lymphoid neoplasms Blood 127 2375-2390

[3] Dupuis J(2000)Peripheral T-cell lymphoma with distinct perifollicular growth pattern: a distinct subtype of T-cell lymphoma? Am J Surg Pathol 24 117-122

[4] Streubel B(2001)Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype Am J Surg Pathol 25 395-400

[5] Petit B(2006)Peripheral T-cell lymphoma with involvement of the expanded mantle zone Virchows Arch 449 78-87

[6] Le Gouill S(2012)Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics Am J Surg Pathol 36 1636-1646

[7] Martin-Garcia N(2004)Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients Blood 104 243-249

[8] Copie-Bergman C(2010)Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma Cancer 116 4541-4548

[9] Gaillard F(2013)A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trial Eur J Cancer 49 2869-2876

[10] Qubaja M(2015)Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T-cell lymphoma Cancer 121 716-723